Meeting
2023 ASCO Annual Meeting
Long-term outcomes of single and five fraction schedules of stereotactic body radiation therapy for early-stage central or peripheral NSCLC: Neither fractionation nor location matter?
Authors
Karen Huang
Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
Karen Huang , Sharan Prasad , Sung Jun Ma , Austin Iovoli , Mark Farrugia , Nadia Karen Malik , Anurag K. Singh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 8538)
DOI
10.1200/JCO.2023.41.16_suppl.8538
Abstract #
8538
Poster Bd #
165
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Survival following stereotactic body radiation therapy or conventionally fractionated radiation for definitive non-operative treatment of stage I non-small cell lung cancer: A review of the National Cancer Data Base.
First Author: Cliff Grant Robinson
Poster
2014 ASCO Quality Care Symposium
Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta, Canada.
First Author: Marc Kerba
Poster
2012 ASCO Annual Meeting
Matched-pair comparison of outcome of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery.
First Author: Julia Shelkey
Poster
2011 ASCO Annual Meeting
Outcomes of stereotactic body radiotherapy in patients with clinical stage I non-small cell lung cancer who are fit to undergo surgery.
First Author: S. Senan